Fenistil Emulsion for external use 0.1%, 8 ml
Category
Allergy
Scope of the medicinal product
Leather
Release form
Emulsion
Manufacturer country
Switzerland
Package quantity, pcs
one
Fenistil emulsion for plank beds.
approx.
0.1% 8ml No. 1
Name ENG
FENISTIL
Clinical and pharmacological group
Antiallergic drug for external use
ATX code
Dimetindene
Dosage
0.1% x 8ml
Structure
1 ml contains dimethindene maleate 1 mg. Excipients: disodium edetate - 50 mg, carbomer - about 900 mg, sodium hydroxide (30% solution) - about 1 g, benzalkonium chloride - 5 mg, propylene glycol - 15 g, purified water - about 82.9 g
Indications
Itching of various origins (except associated with cholestasis) with:
itchy dermatoses
eczema
hives
insect bites.
Sunburns, household and industrial burns (mild).
Contraindications
angle-closure glaucoma
hyperplasia of the prostate
children up to 1 month old (especially premature ones)
hypersensitivity to dimetindene and other components that make up the drug.
Fenistil® should be prescribed with caution in the first trimester of pregnancy and during lactation (breastfeeding).
INN / Active ingredient
Dimetindene
Storage conditions and periods
At a temperature not higher than 30 degrees.
Expiration date: 3 years
Specifications
Category
Allergy
Scope of the medicinal product
Leather
Release form
Emulsion
Manufacturer country
Switzerland
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
1 month
Way of introduction
Locally
,
Outwardly
Vacation conditions
Without recipe
Volume, ml.
8 ml
Brand name
Fenistil
The amount of the dosage form in the primary package
8 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D04AA13 Dimetindene
Dosage form
Emulsion for external use
The target audience
Children
Dosage (volume) of the substance in the preparation
dimethindene maleate 1 mg
Expiration date in days
1095
Package weight, g
ten
Mode of application
:
Applied externally. < br> Fenistil emulsion is applied 2 to 4 times a day on the affected skin. < br> < br>
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker